PT Metro Healthcare Indonesia Tbk(ID:CARE)
Rp338.00-10.00 (-2.87%)
ID:CARE
PT Metro Healthcare Indonesia Tbk financials statements
Rp338.00
At close:-10.00 (-2.87%)
PT Metro Healthcare Indonesia Tbk (CARE) Ratios
PT Metro Healthcare Indonesia Tbk Ratios
ID:CARE's free cash flow for Q3 2026 was Rp1.80B. For the 2026 fiscal year, ID:CARE's free cash flow was decreased by Rp-4.91B and operating cash flow was Rp6.71B. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.84 | 0.62 | 0.88 | 4.14 | 16.15 |
| Quick Ratio | 0.83 | 0.61 | 0.87 | 4.12 | 16.07 |
| Cash Ratio | 0.68 | 0.51 | 0.58 | 2.50 | 6.98 |
| Solvency Ratio | 0.03 | -0.05 | -0.09 | -0.07 | 0.03 |
| Operating Cash Flow Ratio | 0.07 | -0.13 | -0.09 | -0.44 | 0.61 |
| Short-Term Operating Cash Flow Coverage | 0.08 | -0.14 | -0.10 | -0.63 | 2.56 |
| Net Current Asset Value | Rp -638.16B | Rp -459.40B | Rp -244.76B | Rp -146.11B | Rp 341.32B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.23 | 0.23 | 0.23 | 0.20 |
| Debt-to-Equity Ratio | 0.28 | 0.31 | 0.31 | 0.30 | 0.26 |
| Debt-to-Capital Ratio | 0.22 | 0.24 | 0.24 | 0.23 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.04 | 0.04 | 0.20 | 0.20 |
| Financial Leverage Ratio | 1.38 | 1.33 | 1.34 | 1.32 | 1.28 |
| Debt Service Coverage Ratio | 0.15 | 0.02 | -0.01 | 0.08 | 0.70 |
| Interest Coverage Ratio | 0.88 | -0.39 | -0.47 | -0.67 | 0.55 |
| Debt to Market Cap | 0.04 | 0.15 | 0.18 | 0.06 | 0.05 |
| Interest Debt Per Share | 27.50 | 30.73 | 31.02 | 31.49 | 26.16 |
| Net Debt to EBITDA | 4.27 | 20.37 | -48.93 | 22.43 | 9.61 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.93% | 32.78% | 36.94% | 36.95% | 50.16% |
| EBIT Margin | 16.04% | -0.38% | -12.51% | -1.53% | 4.85% |
| EBITDA Margin | 22.02% | 7.62% | -3.61% | 7.26% | 10.79% |
| Operating Profit Margin | 16.04% | -9.38% | -14.89% | -23.27% | 4.85% |
| Pretax Profit Margin | 1.84% | -23.75% | -43.73% | -35.83% | 2.24% |
| Net Profit Margin | 1.13% | -25.17% | -45.71% | -35.92% | 2.10% |
| Continuous Operations Profit Margin | 1.17% | -25.05% | -45.61% | -35.94% | 2.12% |
| Net Income Per EBT | 61.36% | 106.00% | 104.52% | 100.24% | 93.74% |
| EBT Per EBIT | 11.45% | 253.16% | 293.65% | 154.01% | 46.15% |
| Return on Assets (ROA) | 0.12% | -2.00% | -2.68% | -2.21% | 0.14% |
| Return on Equity (ROE) | 0.16% | -2.66% | -3.58% | -2.92% | 0.18% |
| Return on Capital Employed (ROCE) | 1.98% | -0.95% | -1.12% | -1.51% | 0.34% |
| Return on Invested Capital (ROIC) | 1.09% | -0.75% | -0.89% | -1.45% | 0.32% |
| Return on Tangible Assets | 0.12% | -2.00% | -2.69% | -2.21% | 0.15% |
| Earnings Yield | 0.02% | -1.28% | -2.08% | -0.59% | 0.04% |
| Efficiency Ratios | |||||
| Receivables Turnover | 13.53 | 8.07 | 8.04 | 13.13 | 5.69 |
| Payables Turnover | 10.62 | 8.54 | 3.60 | 6.11 | 9.89 |
| Inventory Turnover | 42.02 | 34.21 | 32.02 | 43.09 | 23.66 |
| Fixed Asset Turnover | 0.12 | 0.09 | 0.07 | 0.08 | 0.10 |
| Asset Turnover | 0.11 | 0.08 | 0.06 | 0.06 | 0.07 |
| Working Capital Turnover Ratio | -2.04 | -1.45 | 0.87 | 0.28 | 0.30 |
| Cash Conversion Cycle | 1.29 | 13.12 | -44.64 | -23.47 | 42.63 |
| Days of Sales Outstanding | 26.98 | 45.21 | 45.42 | 27.80 | 64.09 |
| Days of Inventory Outstanding | 8.69 | 10.67 | 11.40 | 8.47 | 15.43 |
| Days of Payables Outstanding | 34.37 | 42.76 | 101.45 | 59.74 | 36.89 |
| Operating Cycle | 35.66 | 55.88 | 56.81 | 36.27 | 79.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.38 | -3.40 | -2.50 | -2.82 | 1.42 |
| Free Cash Flow Per Share | -4.96 | -10.22 | -2.88 | -11.55 | -7.92 |
| Dividend Paid and CapEx Coverage Ratio | 0.22 | -0.50 | -6.61 | -0.32 | 0.15 |
| Capital Expenditure Coverage Ratio | 0.22 | -0.50 | -6.61 | -0.32 | 0.15 |
| Operating Cash Flow Coverage Ratio | 0.06 | -0.12 | -0.09 | -0.10 | 0.06 |
| Operating Cash Flow to Sales Ratio | 0.10 | -0.35 | -0.34 | -0.36 | 0.16 |
| Free Cash Flow Yield | -0.73% | -5.41% | -1.80% | -2.43% | -1.54% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 4533.33 | -78.10 | -47.90 | -169.40 | 2861.11 |
| Price-to-Sales (P/S) Ratio | 51.42 | 19.70 | 21.92 | 60.77 | 58.86 |
| Price-to-Book (P/B) Ratio | 7.48 | 2.08 | 1.72 | 4.94 | 5.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -137.14 | -18.49 | -55.65 | -41.21 | -65.04 |
| Price-to-Operating Cash Flow Ratio | 492.73 | -55.61 | -64.07 | -169.08 | 363.34 |
| Price-to-Earnings Growth (PEG) Ratio | -42.69 | 2.84 | -2.54 | 0.10 | -49.21 |
| Enterprise Value Multiple | 237.74 | 278.80 | -656.04 | 860.07 | 555.03 |
| Enterprise Value | 23.02T | 6.78T | 5.75T | 16.25T | 17.43T |
| EV to EBITDA | 237.74 | 278.80 | -656.04 | 860.07 | 555.03 |
| EV to Sales | 52.36 | 21.25 | 23.69 | 62.40 | 59.89 |
| EV to Free Cash Flow | -139.65 | -19.94 | -60.14 | -42.31 | -66.19 |
| EV to Operating Cash Flow | 501.75 | -59.99 | -69.23 | -173.61 | 369.74 |
| Tangible Book Value Per Share | 90.94 | 90.78 | 92.95 | 96.24 | 98.99 |
| Shareholders’ Equity Per Share | 90.89 | 90.73 | 93.13 | 96.42 | 99.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.36 | -0.05 | -0.04 | -0.00 | 0.05 |
| Revenue Per Share | 13.23 | 9.59 | 7.30 | 7.83 | 8.75 |
| Net Income Per Share | 0.15 | -2.42 | -3.34 | -2.81 | 0.18 |
| Tax Burden | 0.61 | 1.06 | 1.05 | 1.00 | 0.94 |
| Interest Burden | 0.11 | 63.20 | 3.50 | 23.43 | 0.46 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.03 | 0.04 | 0.06 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 9.26 | 1.41 | 0.75 | 1.00 | 7.73 |
Currency in IDR
